ISCoS 2026 Abstract Submission

Submit Your Abstract for ISCoS 2026

Abstract Submission for ISCoS 2026 is now open. We welcome clinicians, researchers, scientists, and early-career investigators to share their work and contribute to global advancements in spinal cord injury (SCI) care. Presenting at ISCoS 2026 provides international exposure, collaboration with leading experts, and the opportunity to strengthen the impact of your research.

Submit your abstract and join a global SCI community advancing innovation, rehabilitation, and improved outcomes. Download the abstract guidelines as a PDF

ISCoS 2026 Abstract Submission Portals

Abstract Submission is Now OPEN

Submit your abstract using the official ISCoS 2026 portals below.

Guidelines for Abstract Submission

Presentation Types

  • 75-minute Instructional Course / Workshop
  • Oral Presentation
  • Poster Presentation

Rules for Content and Structure

  • All speakers must disclose any conflict of interest through the abstract submission process.
  • Abstracts may include high impact papers previously published; the publication date must be indicated.
  • Maximum 500 words (excluding title, author names, and affiliations).
  • All co-authors must be listed.
  • No images, tables, or graphs permitted.
  • No promotional content for commercial entities, products, or services.
  • Ensure no information identifying an individual is included without written permission. For workshops, consider inviting the individual or a nominee to contribute a personal perspective.

Rules for Submission

  • Submitting an abstract grants ISCoS permission to publish the content on the ISCoS website.
  • Authors invited to present grant ISCoS permission to record and publish their presentation for post-event viewing.
  • All abstracts must be submitted through the official online abstract submission portal.

Most Frequent Reasons for Abstract Rejection

  • Incomplete results or preliminary data.
  • Promotional or commercial content.
  • Duplicate submission of another abstract.

Review outcomes will be emailed to the submitting author by 30 April 2026.

Accepted abstracts will be cancelled if the presenting author has not registered and paid the registration fee by 1 August 2026. Abstracts without confirmed presenters cannot be scheduled or published.


Important Dates

  • 10 March 2026 (23:59 UK Time): Abstract Submission Deadline
  • 30 April 2026: Review outcomes communicated
  • 1 August 2026: Presenting author registration deadline

A 75-minute session is appropriate for an in-depth overview of recent research evidence and/or translation into clinical practice of an innovative, evidence-based topic. Workshop sessions typically are interactive, focused on developing participants’ skills (e.g., new assessments, techniques, treatments, guideline implementation) whereas instructional courses are didactic (e.g., presentation of large or multicentre clinical trial results, overview or in-depth review of a novel topic or new research findings). The session cannot include more than 5 presenters including the session Chair, allowing a minimum of 15 minutes for discussion that is best distributed throughout the session. Submissions with more than 5 presenters will not be considered. All presenting speakers and the session Chair must register as a delegate and pay at the appropriate rate to present at the Meeting. Proposals that are interdisciplinary and involve presenters from a range of institutions and academic rank are encouraged. Very few 75-minute sessions will be accepted, thus applicants are encouraged to submit only topics that are recent, innovative, novel and/or that address a glaring gap/need in the field. The 75-minute session abstract outline (#7 below) is limited to 500 words.

Single centre or small clinical trials, case studies, systematic reviews are best presented in other formats (see below).

Required information is as follows and this information MUST be included, or your abstract will not be considered:

  1. Title of course.
  2. Speakers (name, credentials, institution, country) – maximum of 5 (including the session Chair). No reasons for special consideration or exemption will be accepted.
  3. List up to 3 learning objectives.
  4. State whether material is for participants at an ‘Introductory’, ‘Intermediate’ or ‘Advanced’ level or whether any level is suitable.
  5. Indicate the target audience (physicians, nurses, physios, researchers, consumers, etc).
  6. Briefly state whether any prior learning, experience or qualifications, or pre-reading are recommended or essential for optimal participation.
  7. Outline of the 75-minute session – please provide a detailed time schedule that indicates when and for how long each speaker will present, and the time of audience interaction and questions.
  8. If your 75-minute session involves demonstration of assistive technology or other equipment, please describe what you will bring, how much space will be required, and how much time is needed for set-up and removal. Please note that any costs incurred, or labour required for transport and set up of technology or equipment will be the responsibility of the workshop presenters.
  9. Speakers must provide disclosure information about potential conflicts of interest and avoid any commercialization, promotion or advertising of products or materials.

Review criteria for an Instructional Course / Workshop may be found here.

 

ROOM SETUP & ADDITIONAL REQUESTS
Please note that all allocated session rooms are setup in Theatre style as standard. Unfortunately, we are unable to accommodate any other room setup request due to limited turnaround time. 

Any additional requests and/or equipment, if available, may be provided at a cost i.e. flipcharts, notepads and pens, etc. 

Short oral presentations are intended as a brief synopsis of either (i) completed primary research or (ii) description of interesting and novel initiatives/ programmes. Opportunities for discussion are limited. Short oral presentations will be 8 minutes in length plus 4 minutes for discussion. The entire abstract (#5 below) is limited to 500 words. Figures and references are discouraged in the abstract due to space constraints. Abstracts of research that state “results will be presented” or that only provide results of interim analyses will be rejected. Although multiple oral presentations may be submitted, the presenting author may only present once.

Required information for submitting an oral abstract is as follows:

  1. Title of presentation.
  2. Authors (name, credentials, institution, country) with the presenting author’s name appearing first.
  3. Type of abstract: Research or Initiative/programme.
  4. Format of abstract:
    (i) Research: Introduction, methods, results, conclusions.
    (ii) Initiative/programmes: Introduction, description, impact, conclusions
  5. The entire abstract is limited to 500 words.

Review criteria for a Short Oral Presentation may be found here.

Posters provide an opportunity for feedback and detailed discussion with meeting attendees who have a specific interest in your topic. A poster is ideal for developing research in which feedback is useful. It is also an appropriate medium to showcase novel initiatives or programmes. Examples of topics for posters include case studies, single country epidemiology studies, systematic reviews or programme development with a needs assessment or supporting evidence of programme effectiveness. The entire abstract (#5 below) is limited to 500 words. Figures and references are discouraged in the abstract due to space constraints. Abstracts of research that state “results will be presented” or that only provide results of interim analyses will be rejected. Although multiple poster abstracts may be submitted, the primary presenter will be limited to four posters. Posters submitted by junior researchers/clinicians are encouraged.

Required information for submitting a poster abstract is as follows:

  1. Title of presentation.
  2. Authors (name, credentials, institution, country) with the presenting author’s name appearing first.
  3. Type of abstract: Research or Initiative/Programme
  4. Format of abstract:
    (i) Research: Introduction, methods, results, conclusions.
    (ii) Initiative/programmes: Introduction, description, impact, conclusions.
  5. The entire abstract is limited to 500 words.

Review criteria for a Poster Presentation may be found here.

Poster Awards and (NEW) Oral Presentation Awards

ISCoS will award 2 nominal cash prizes in 3 distinct categories for both posters and oral submissions (total of 12 prizes):

Student: Open to Undergraduate, Honours, Master’s, or PhD students enrolled at the time of submission or within 6 months of completing their degree. The student must be the presenting author and have made a major contribution to the work.  Supervisors may be co-authors but cannot present on the student’s behalf. Students must also provide the name and email of their most direct supervisor.

Early Career Clinician/Scholar: Open to clinicians, researchers, or academics within 5 years (FTE) of completing their highest degree (e.g., PhD, MD, or master’s). Must be the lead and presenting author. Those primarily in full-time senior academic or leadership roles are not eligible.

Open: Open to all other presenters, including senior academics, clinicians, or researchers. Must be the lead and presenting author.

An initial short list of 5 abstracts for each of the 3 categories for both posters and oral submissions will be selected based on the tallied assessors’ score of the submitted abstracts.

Those on the short list for a poster prize will be required to submit an electronic copy of their poster prior to the conference for judgement. Those on the short list for an oral submission prize will be required to record and submit their presentation prior to the conference for judgement.

Candidates must declare the appropriate category on the abstract submission form to be considered eligible for an award.

The awards will be presented in the name of Dr Hans Frankel who is an eminent contributor to the field of spinal cord injury and a founding member of the ISCoS organization.

Should you not wish to be considered, you may opt out.

Note:

  • To be eligible for a poster award, your original abstract submission must be a poster submission. If your submission was for an oral presentation but accepted as poster, this will not qualify for a poster award.
 

All winners will be presented in an oral session on Day 1 of the Annual Scientific Meeting (exact time and location to be determined). Prize winners will be notified prior to the conference that they will be making an oral presentation during that session. In addition, prize winning posters will be in a highly visible location in the poster viewing area and will remain up during the entire ISCoS Meeting.

 

For all abstract submissions, you will receive notification that the abstract has been received via the submission system. If you do not receive notification within 24 hours of submitting your abstract(s), please contact:

Daisy Lam, ISCoS Abstract Management Team

Email: iscos@associationsltd.co.uk

All submissions will be independently peer-reviewed based on the criteria in each category (links provided above). The Scientific and Research Committee reserves the right to offer an alternative mode of presentation based on submissions.

Late submissions will not be accepted. If you have issues regarding submission by the deadline, please contact Daisy Lam or ISCoS Headquarters at admin@iscos.org.uk prior to the submission deadline.

Receive Updates

Register Your Interest

Please complete the form below to receive the ISCoS 2026 Sponsorship & Exhibition Prospectus once available.